Enhanced Classification of Prostate Cancer Datasets using Supervised Machine Learning Models

Main Article Content

Raji Sundararajan
JD Bensho Sulfick Singh

Abstract

Prostate cancer is one of the most frequently diagnosed cancers among men worldwide and remains a major cause of cancer-related mortality, with over 1.4 million new cases and approximately 375,000 deaths reported annually. Accurate classification of patients into high- and low-risk groups, commonly guided by clinical indicators, such as the Gleason score and prostate-specific antigen (PSA), is essential for early diagnosis and effective treatment planning. In this study, five publicly available datasets were analyzed using seven supervised machine learning models, including Logistic Regression, Naïve Bayes, Decision Tree, Support Vector Machine (SVM), K-Nearest Neighbors (KNN), Random Forest, and Extreme Gradient Boosting (XGBoost). Model performance was evaluated using accuracy, precision, recall, and F1-score. Sensitivity, specificity, the area under the ROC curve (AUC) with 95% confidence intervals, the Brier score and a simple majority-class baseline were also reported. Random Forest showed the highest accuracy of 92.00% with 100% recall in Prostate Adenocarcinoma Dataset 1, while XGBoost showed the highest accuracy of 72.50% in Dataset 2, XGBoost, the highest accuracy of 87.66% in Dataset 3, KNN, the highest accuracy of 90.02% in Dataset 4, and again Random Forest, the highest accuracy of 87.50% with 100% recall in Dataset 5. Across all the datasets, ensemble-based approaches, such as Random Forest and XGBoost consistently demonstrate more balanced and reliable performance, particularly in maintaining high recall, which is critical for minimizing false negatives in medical diagnosis. These findings highlight the effectiveness of machine learning models for prostate cancer risk classification and emphasize the importance of selecting appropriate models based on dataset characteristics. Before any clinical use, the models need further validation.

Downloads

Download data is not yet available.

Article Details

Sundararajan, R., & Sulfick Singh, J. B. (2026). Enhanced Classification of Prostate Cancer Datasets using Supervised Machine Learning Models. Journal of BioData Mining, 1(1), 1–17. https://doi.org/10.17352/jbdm.000003
Research Articles

Copyright (c) 2026 Sundararajan R, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Kratzer TB, Mazzitelli N, Star J, Dahut WL, Jemal A, Siegel RL. Prostate cancer statistics, 2025. CA Cancer J Clin. 2025. doi: 10.3322/caac.70028.

American Cancer Society. Risk groups and lab tests to help determine risk from localized prostate cancer [Internet]. Available from: https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/risk-groups.html. [cited 2026 Mar 31].

Nitta S, Tsutsumi M, Sakka S, Endo T, Hashimoto K, Hasegawa M, et al. Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity. Prostate Int. 2019.

KOELIS. What is the Gleason score? [Internet]. Available from: https://koelis.com/what-is-the-gleason-score/. [cited 2026 Mar 31].

Reisenauer K. Prostate cancer risk assessment. BioRender [Internet]. 2023. Available from: https://biorender.com/template/prostate-cancer-risk-assessment.

Rustam Z, Angie N. Prostate cancer classification using random forest and support vector machines. J Phys Conf Ser. 2021;1752(1).

Géron A. Hands-on machine learning with Scikit-Learn, Keras, and TensorFlow. Sebastopol (CA): O’Reilly Media; 2019.

Kourou J, et al. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8-17.

Xiao L, et al. Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen. Asian J Androl. 2017;19(5):586-590.

Lay N, et al. Detection of prostate cancer in multiparametric MRI using random forest with instance weighting. J Med Imaging (Bellingham). 2017;4(2).

Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995;20(3):273-297.

Özhan S, Yağın F. Machine learning approach for classification of prostate cancer based on clinical biomarkers. J Cogn Syst. 2022;7(2).

Sakouvogui K. Comparative classification of prostate cancer data using support vector machine and random forest, DualKS and K-nearest neighbors [thesis]. Fargo (ND): North Dakota State University; 2015.

Zheng H, Miao Q, Liu Y, Raman SS, Scalzo F, Sung K. Integrative machine learning prediction of prostate biopsy results from negative multiparametric MRI. J Magn Reson Imaging. 2022;55(1):100-110.

Chen T, Guestrin C. XGBoost: A scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (KDD ‘16); 2016. p. 785-794. Available from: https://arxiv.org/abs/1603.02754. [cited 2026 Aug].

Dubey P, Kumar S. Advancing prostate cancer detection: A comparative analysis of PCLDA-SVM and PCLDA-KNN classifiers for enhanced diagnostic accuracy. Sci Rep. 2023;13.

Chen S, Jian T, Chi C, Liang Y, Liang X, Yu Y, et al. Machine learning-based models enhance the prediction of prostate cancer. Front Oncol. 2022;12:941349.

cBioPortal for Cancer Genomics. Prostate adenocarcinoma (Broad, Cell 2012) [Internet]. Available from: https://www.cbioportal.org/study/summary?id=prad_broad. [cited 2026 Mar].

cBioPortal for Cancer Genomics. Prostate adenocarcinoma (MSK, Cancer Cell 2010) [Internet]. Available from: https://www.cbioportal.org/study/summary?id=prad_mskcc. [cited 2026 Apr 14].

cBioPortal for Cancer Genomics. Race differences in prostate cancer (MSK, 2021) [Internet]. Available from: https://www.cbioportal.org/study/summary?id=prad_msk_stopsack_2021. [cited 2026 Apr 14].

cBioPortal for Cancer Genomics. Prostate adenocarcinoma (MSK, PNAS 2014) [Internet]. Available from: https://www.cbioportal.org/study/summary?id=prad_mskcc_2014. [cited 2026 Apr 13].

cBioPortal for Cancer Genomics. Prostate adenocarcinoma (TCGA, PanCancer Atlas) [Internet]. Available from: https://www.cbioportal.org/study/summary?id=prad_tcga_pan_can_atlas_2018. [cited 2026 Apr 14].

Berrar D. Cross-validation and train test split in medical machine learning. In: Encyclopedia of Bioinformatics and Computational Biology. 2019.

Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. 2nd ed. New York: Springer; 2009.

Altman DG, Bland JM. Diagnostic tests 1: Sensitivity and specificity. BMJ. 1994;308(6943):1552.

Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett. 2006;27(8):861-874.

Brier GW. Verification of forecasts expressed in terms of probability. Mon Weather Rev. 1950;78(1):1-3.

Ting KM. Confusion matrix. In: Sammut C, Webb GI, editors. Encyclopedia of machine learning. Boston (MA): Springer; 2011. doi: 10.1007/978-0-387-30164-8_157.

Atlassian. A complete guide to heatmaps [Internet]. Available from: https://www.atlassian.com/data/charts/heatmap-complete-guide. [cited 2026 Apr 14].